Red blood cell alloantibodies in paediatric transfusion in sub‐Saharan Africa: A new cohort and literature review
eJHaem · 2023-05 · 4 (2) · 315-323
DOI: 10.1002/jha2.645 ↗Kurz gefasst
Fachartikel in der Zeitschrift eJHaem, online erschienen am 09.02.2023. Verfasst von Macoura Gadji und 12 weiteren Autor:innen. Beteiligte Einrichtung: Service of Haematology and Oncology-Haematology (HBOH) Department of Biology and Applied Pharmaceutical Sciences Faculty of Medicine Pharmacy and Odo…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Blood transfusion support predisposes transfused children to the risk of erythrocyte alloimmunization in Sub‐Saharan Africa. A cohort of 100 children receiving one to five blood transfusions were recruited for screening and identification of irregular antibodies using gel filtration technique. The mean age was 8 years and the sex‐ratio at 1.2. The retrieved pathologies were: major sickle cell anaemia (46%), severe malaria (20%), haemolytic anaemia (4%), severe acute malnutrition (6%), acute gastroenteritis (5%), chronic infectious syndrome (12%) and congenital heart disease (7%). The children presented with haemoglobin levels ≤6 g/dl, and 16% of them presented positive irregular antibodies directed against the Rhesus (30.76%) and Kell (69.24%) blood group systems. A literature review shows that irregular antibody screenings vary from 17% to 30% of transfused paediatric patients in Sub‐Saharan Africa. These alloantibodies are in particular directed against the Rhesus, Kell, Duffy, Kidd and MNS blood group and generally found in sickle cell disease and malaria. This study highlights the urgent need of extended red blood cell phenotyping including typing for C/c, E/e, K/k, and Fya/Fyb, and if possible Jka/Jkb, M/N, and S/s for children before transfusion in Sub‐Saharan Africa.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service of Haematology and Oncology-Haematology (HBOH) Department of Biology and Applied Pharmaceutical Sciences Faculty of Medicine Pharmacy and Odonto-Stomatology (FMPOS) University Cheikh Anta Diop of Dakar (UCAD) Da…
- National Centre of Blood Transfusion (CNTS) Dakar Senegal.
- Service of Paediatrics Department of Medicine, Hospital Albert Royer of Fann Faculty of Medicine Pharmacy and Odonto-Stomatology (FMPOS) University Cheikh Anta Diop of Dakar (UCAD) Dakar Senegal.
- Service of Haematology Department of Medicine, Faculty of Medicine Pharmacy and Odonto-Stomatology (FMPOS) University Cheikh Anta Diop of Dakar (UCAD) Dakar Senegal.
- Service of Biology Hospital Aristide le Dantec Dakar Senegal.
- Service of Immunology Department of Biology and Applied Pharmaceutical Sciences Faculty of Medicine Pharmacy and Odonto-Stomatology (FMPOS) University Cheikh Anta Diop of Dakar (UCAD) Dakar Senegal.
ORCID-Profile: Macoura Gadji, Moussa Seck
Zitieren
APA
Gadji, M., Cobar, G., Thiongane, A., Senghor, A. B., Seck, R., Faye, B. F., Seck, M., Guéye, Y. B., Sy, D., Sall, A., Toure, A. O., Diéye, T. N., & Diop, S. (2023). Red blood cell alloantibodies in paediatric transfusion in sub‐Saharan Africa: A new cohort and literature review. eJHaem, 4(2), 315-323. https://doi.org/10.1002/jha2.645
Vancouver
Gadji M, Cobar G, Thiongane A, Senghor AB, Seck R, Faye BF, et al. Red blood cell alloantibodies in paediatric transfusion in sub‐Saharan Africa: A new cohort and literature review. eJHaem. 2023;4(2):315-323. doi:10.1002/jha2.645
BibTeX
@article{Gadji2023,
author = {Gadji, Macoura and Cobar, Guéda and Thiongane, Alioune and Senghor, Alioune Badara and Seck, Rose and Faye, Blaise Félix and Seck, Moussa and Guéye, Youssou Bamar and Sy, Diariétou and Sall, Abibatou and Toure, Awa Oumar and Diéye, Tandakha Ndiaye and Diop, Saliou},
title = {Red blood cell alloantibodies in paediatric transfusion in sub‐Saharan Africa: A new cohort and literature review},
journal = {eJHaem},
year = {2023},
volume = {4},
number = {2},
pages = {315--323},
doi = {10.1002/jha2.645}
}
EUVIMED